Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
17.98
0.34 (1.93%)
At close: Aug 15, 2025, 1:21 PM
Centessa Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15M | n/a | 6.91M | 6.91M | 6.91M | 6.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 681.96K | 703.99K | 724.26K | 960.88K | 962.38K | 812.33K | 600.46K | 398.54K | 192.5K | 130.53K | 106.28K | 71.57K | 39.85K | 14.02K | 2.01K | 2.01K | 2.01K |
Gross Profit | 14.6M | -476K | 6.19M | 5.95M | 5.95M | 6.1M | -601.08K | -398.78K | -192.5K | -130.53K | -79.31K | -57.55K | -25.83K | n/a | -14.95K | -2.01K | -2.01K |
Operating Income | -195.74M | -201.06M | -161.65M | -155.46M | -158.5M | -171.28M | -177.71M | -186.53M | -207.92M | -212.26M | -228.95M | -218.24M | -191.11M | -156.91M | -101.63M | -65.43M | -26.27M |
Interest Income | 19.32M | 14.02M | 12.1M | 11.72M | 10.54M | 10.48M | 7.55M | 4.67M | 2.64M | 208.16K | 206K | 194K | 196K | 130K | 232K | 267K | 329K |
Pretax Income | -220.56M | -233.37M | -159.09M | -158.18M | -163.96M | -176.91M | -184.74M | -197.28M | -213.03M | -216.95M | -233.78M | -219.92M | -196.68M | -382.55M | -325.18M | -287.16M | -247.94M |
Net Income | -223.85M | -235.74M | -161.56M | -157.65M | -138.72M | -151.41M | -157.42M | -172.65M | -212.42M | -216.21M | -233.81M | -220.09M | -196.88M | -382.67M | -325.18M | -287.16M | -247.94M |
Selling & General & Admin | 49.71M | 50.56M | 49.03M | 48.55M | 50.73M | 53.59M | 55.18M | 55.45M | 56.87M | 55.2M | 54.42M | 54.6M | 51.68M | 43.01M | 30.33M | 18.06M | 6.47M |
Research & Development | 173.08M | 162.28M | 119.33M | 113.62M | 114.48M | 124.66M | 122.52M | 131.08M | 151.06M | 155.08M | 172.71M | 161.82M | 126.3M | 100.22M | 55.76M | 32.48M | 16.22M |
Other Expenses | 1.54M | 1.54M | n/a | n/a | n/a | n/a | -70K | -70K | -70K | 126K | 431K | 431K | 431K | -1.91M | -438K | -1.09M | -1.09M |
Operating Expenses | 210.74M | 200.79M | 168.36M | 162.17M | 165.21M | 178.25M | 177.71M | 186.53M | 207.92M | 210.28M | 223.2M | 212.49M | 174.05M | 141.83M | 90.49M | 54.22M | 26.38M |
Interest Expense | 10.44M | 10.09M | 10.18M | 10.16M | 10.09M | 9.91M | 9.5M | 8.88M | 8.08M | 7.24M | 6.35M | 4.42M | 2.77M | 1.27M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -248K | -389K | -389K | -389K | -141K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 165.7M | 201.77M | 168.85M | 162.66M | 165.69M | 178.5M | 177.71M | 186.53M | 207.92M | 212.26M | 228.95M | 218.24M | 191.11M | 156.91M | 101.81M | 65.53M | 26.38M |
Income Tax Expense | 3.76M | 2.84M | 2.95M | -486.27K | -25.24M | -25.05M | -26.86M | -24.18M | -150K | -747K | 31K | 107K | 129K | 49K | -65K | 3.07 | 3.07 |
Shares Outstanding (Basic) | 133.03M | 132.05M | 116.25M | 109.49M | 99.89M | 97.92M | 96.65M | 95.16M | 94.94M | 94.6M | 94.33M | 94.11M | 90.5M | 89.94M | 89.9M | 63.52M | 87.42M |
Shares Outstanding (Diluted) | 133.03M | 132.05M | 116.25M | 109.49M | 99.89M | 97.92M | 96.65M | 95.16M | 94.94M | 94.6M | 94.33M | 94.11M | 90.5M | 89.94M | 89.9M | 63.52M | 87.42M |
EPS (Basic) | -1.81 | -1.99 | -1.53 | -1.56 | -1.42 | -1.57 | -1.64 | -1.81 | -2.24 | -2.31 | -2.54 | -2.42 | -2.38 | -4.53 | -3.88 | -3.45 | -2.82 |
EPS (Diluted) | -1.81 | -1.99 | -1.53 | -1.56 | -1.42 | -1.57 | -1.64 | -1.81 | -2.24 | -2.31 | -2.54 | -2.42 | -2.38 | -4.53 | -3.88 | -3.45 | -2.82 |
EBITDA | -207.73M | -220.88M | -147.19M | -146.72M | -152.62M | -165.43M | -174.19M | -187.55M | -204.3M | -209.58M | -226.16M | -214.06M | -192.35M | -379.7M | -324.49M | -284.55M | -243.36M |
EBIT | -209.18M | -222.25M | -148.57M | -147.48M | -153.33M | -166.01M | -174.56M | -187.58M | -203.6M | -208.63M | -225.14M | -213.39M | -192.25M | -379.77M | -324.59M | -286.73M | -247.49M |
Depreciation & Amortization | 919.29K | 942.15K | 962.42K | 960.62K | 962.38K | 759.52K | 547.65K | 345.73K | 139.69K | 130.53K | 72.31K | 50.55K | 25.83K | n/a | 23.45K | 2.13M | 4.25M |